Schedule 13D ownership disclosure
Black Diamond Therapeutics Inc
Security class unavailable · CUSIP: 09203E105
Event date: 2023-08-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-274632
- Form type
- SC 13D
- Filer
- Black Diamond Therapeutics, Inc.
- CIK
- CIK 1701541
- Filed
- Nov 09, 2023
- Reporting period
- Aug 11, 2023
- Description
- Schedule 13D beneficial ownership